Mandate

Vinge advises EQT Infrastructure II fund on the acquisition of Hector Rail

September 16, 2014

Vinge advises EQT Infrastructure II fund in connection with the acquisition of a majority stake in Hector Rail AB, a leading Sweden-based independent rail freight company, from investment entities advised by Höegh Capital Partners, the founders Mats Nyblom and Ole Kjörrefjord, and other minority owners. Hector Rail was founded in 2004, supported by the Norwegian Høegh family. The Company, headquartered in Stockholm, Sweden, has around 190 employees operating in Sweden, Norway, Denmark and Germany.

Hector Rail offers environmentally friendly transportation services of heavy industry products, raw materials, intermodal freight and passengers to clients such as industrial companies, forwarders, and other rail companies under medium term contracts. The Company currently operates a fleet of around 50 locomotives and 10 shunters performing over 6 million train kilometres per year. Revenues amounted to approximately SEK 630 million in 2013.

Vinge’s team consisted of responsible partner Daniel Rosvall together with, amongst others, project manager Matthias Pannier and associate Maria Dahlin (all corporate).

Related

Vinge has advised Egetis Therapeutics in connection with a directed share issue

Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025

Vinge worked with funds advised by Agilitas on the buy-out of Vivicta (previously Tietoevry Tech Services), including on the issuance of senior secured bonds and on entering into a super senior RCF

Vinge, together with O’Melveny as lead counsel and Avance, worked with funds advised by Agilitas Private Equity LLP (“Agilitas”), the pan-European mid-market private equity firm, in their backing of Vivicta. The buy-out was previously announced on 24 March 2025 and closed on 2 September 2025.
October 03, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 671.5 million

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of approx. SEK 671.5 million before transaction costs.
October 03, 2025